title: Cystic fibrosis, Pseudomonas aeruginosa, and selective decontamination.
abstract: We used an oral topical antibiotic preparation to try and prevent oropharyngeal carriage of Pseudomonas aeruginosa in patients with cystic fibrosis. Ten of 15 patients treated with a two week course of intravenous ceftazidime together with a 90 day course of an antibiotic containing gel continued to carry P aeruginosa in the oropharynx.
authors: Royal Liverpool Children's Hospital, Alder Hey.
authors: A M
authors: AM
authors: Dalzell
authors: H K
authors: HK
authors: van Saene
authors: D P
authors: DP
authors: Heaf
mesh_terms: D000284:Administration, Oral; D002353:Carrier State / Q000517:prevention & control*; D002442:Ceftazidime / Q000008:administration & dosage / Q000627:therapeutic use*; D002675:Child, Preschool; D003550:Cystic Fibrosis / Q000150:complications* / Q000382:microbiology; D006801:Humans; D007223:Infant; D009960:Oropharynx / Q000382:microbiology; D010865:Pilot Projects; D011552:Pseudomonas Infections / Q000517:prevention & control*; D011550:Pseudomonas aeruginosa / Q000302:isolation & purification
chemical_list: D002442:Ceftazidime